Dysfunction of microRNA (miRNA) metabolism is thought to underlie diseases affecting motoneurons. One miRNA, miR-218, is abundantly and selectively expressed by developing and mature motoneurons. Here we show that mutant mice lacking miR-218 die neonatally and exhibit neuromuscular junction defects, motoneuron hyperexcitability, and progressive motoneuron cell loss, all of which are hallmarks of motoneuron diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy. Gene profiling reveals that miR-218 modestly represses a cohort of hundreds of genes that are neuronally enriched but are not specific to a single neuron subpopulation. Thus, the set of messenger RNAs targeted by miR-218, designated TARGET
M
otoneurons are a specialized neuronal subpopulation within the central nervous system (CNS) that establish synaptic connections with muscles to regulate movement. Diseases such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), which affect motoneurons, appear to share a common pathogenic mechanism based on defective RNA metabolism and biogenesis of microRNAs (miRNAs) (1) (2) (3) (4) (5) . Consistent with earlier descriptions of miR-218 expression in embryonic motoneurons (6, 7), we found that miR-218 was the most abundant motoneuron miRNA and was enriched~27-fold, as determined by small RNA sequencing (RNA-seq) of embryonic mouse spinal cord Hb9::gfp + motoneurons purified by fluorescence-activated cell sorting (FACS) (Fig. 1A and supplementary materials and methods). The spinal cord is composed of many interneuron subtypes (8) . We found that V2a and V3 ventral spinal interneurons did not express a single characteristic miRNA ( fig. S1A ), indicating that motoneurons may be distinctly reliant on cell type-specific miRNA expression.
We detected miR-218 within visceral and somatic spinal (Fig. 1B and fig. S1B ) and brainstem motoneurons ( fig. S1C ). Robust miR-218 expression was detected postnatally in choline acetyltransferase (ChAT)-positive a and g motoneurons ( Fig. 1C and fig. S1D ) but not ChAT + interneurons ( fig. S1E ). Likewise, miR-218 was selectively expressed in human embryonic motoneurons (fig. S1F). Compared with the extensive catalog of protein markers that delineate motoneuron subtypes (8) , miR-218 is notable for its expression spanning motoneuron classes from embryonic stages into adulthood (fig. S1G) and its undetectable expression in other tissues.
Two mammalian paralogs of miR-218, miR-218-1 and miR-218-2, are embedded within homologous introns of the Slit2 and Slit3 genes, respectively. It has been suggested that the motoneuron-specifying transcription factors Isl1 and Lhx3 up-regulate miR-218 by increasing transcription of Slit2 and Slit3 (6). We used RNAseq to investigate Slit2 and Slit3 mRNA expression in motoneurons and discovered that both genes were transcribed using start sites located upstream of exon 6 ( Fig. 1D and fig. S2, A and B) . This intronic start site was not used by adjacent floor-plate glial cells expressing Slit2 and Slit3. Previously mapped Isl1/2, Lhx3, and Phox2a chromatin immunoprecipitation (ChIP) peaks (9) were observed at conserved hexamer DNA response elements (HxREs) proximal to exon 6 (Fig. 1E) , suggesting the presence of intragenic motoneuronspecific promoters (Fig. 1F) . To test this hypothesis, we generated a transgenic mouse line, tg(218-2::eGFP), with a 7.4-kb sequence containing putative regulatory elements ( fig. S2C ). In vivo, enhanced green fluorescent protein (eGFP) was expressed in tg(218-2::eGFP) spinal and cranial motoneurons, reproducing the endogenous expression pattern of miR-218 (Fig. 1, G and H, and  fig. S2C ). These findings demonstrate that primary miR-218 transcripts are under independent activation in motoneurons by promoters distinct from those that generate Slit2 and Slit3 fulllength transcripts in other tissues.
Studies in vitro and in chick embryos have suggested that miR-218 may contribute to motoneuron specification (6) . However, such miRNA knockdown and overexpression studies can yield nonphysiological effects (10) . To determine the biological effect of miR-218 disruption in vivo, we used clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene editing (11) to create microdeletions of miR-218-1 and miR-218-2 precursor sequences in mice ( Fig. 2A and  fig. S3, A to D DKO embryos exhibited akinesia, kyphosis, and weak or absent responses to pain stimulation after caesarean delivery at E18.5 and died within minutes due to an apparent lack of respiration ( Fig. 2C and movie S1 ). These phenotypic defects are similar to those observed in mice carrying null alleles of Agrin, MuSK, ChAT, and other components required for neuromuscular transmission (14) . Consequently, we investigated whether the loss of miR-218 affects neuromuscular synaptogenesis, an intricate process in which motor nerves first innervate muscle and subsequently form presynaptic specializations with postsynaptic acetylcholine receptors (AChRs) expressed by developing muscle (15) . We examined glycerolcleared tg(218-2::eGFP) embryos and found that the motor nerves of 218 DKO motoneurons reached E14.5 limb tissue ( fig. S5B ). However, motor axons appeared to lack penetrating, fine intramuscular branches in limbs, the diaphragm, and intercostal muscles (Fig. 2, D fig. S8, B to J) . However, action potentials were elicited by a rheobase current that was 4.4 times lower in 218 DKO motoneurons than in controls (Fig. 2, I and J), indicating membrane hyperexcitability. Thus, miR-218 does not appreciably contribute to early motoneuron development, but it is critical for the regulation of neuromuscular synapses, membrane excitability, and motoneuron survival.
These phenotypic defects suggest that motoneuronspecific gene regulation depends on the posttranscriptional repression of miR-218 target mRNAs. To extend beyond miRNA target identification studies performed in vitro using cancer cell lines (6, 17) E12.5 spinal cords, before the apparent onset of defects ( fig. S9A ). Using Sylamer (18), we determined that 6-, 7-, and 8-base pair (bp) 3′ untranslated region (3′UTR) complementary seed matches to miR-218 were enriched within genes expressed higher in 218 DKO motoneurons versus controls ( fig. S9, B to E) . This finding reflects the widespread derepression of miR-218 target genes in 218 DKO motoneurons.
We identified 333 genes with predicted miR-218 binding sites [TargetScan 6.2 (19) ] that were significantly derepressed in 218 DKO versus WT motoneurons (Fig. 3A) . We name this coordinately regulated gene set, likely to be under direct miR-218-mediated repression, TARGET
218
. TARGET 218 genes are enriched for neurotransmission and neurotransmitter transport processes ( fig. S9 , F and G). The most highly up-regulated TARGET 218 gene, Slc1a2 (266% increase), is a glutamate reuptake transporter known to be modulated by riluzole, the only medication approved for the treatment of ALS (20) . On average, TARGET 218 genes were expressed 61.1% higher in 218 DKO motoneurons, and 47 of these genes were expressed at least twofold higher (table S1). The wide breadth of target genes affected in 218 DKO motoneurons suggests that miR-218 shapes expression of an extensive genetic network rather than merely modulating a small group of individual genes within a single molecular pathway.
Other miRNA gene regulatory networks have been shown to reinforce the repression of SCIENCE sciencemag.org 18 differentiation programs to confer robustness to cell fate decisions (21) (22) (23) . However, the lack of cell specification errors in 218 DKO embryos suggests that miR-218 might have a previously unrecognized regulatory role. To evaluate whether the TARGET 218 gene network was expressed higher or lower in motoneurons compared with other spinal neuronal subpopulations, we performed gene profiling of FACS-purified interneuron subpopulations labeled by genetic reporters: GABAergic-V1 (En1:Cre), glutamatergic-V2a (Chx10:Cre), and glutamatergic-V3 (Sim1:Cre) spinal interneurons (Fig. 3B and fig.  S10 , A to C). We found that~80% of TARGET 218 genes are expressed lower in WT motoneurons versus each of the V1, V2a, and V3 interneurons (Fig. 3C) . Moreover, the majority (69.1%) of TARGET 218 genes are expressed lower in WT motoneurons versus all three spinal interneuron subpopulations (Fig. 3D) . These findings suggest that miR-218 represses a gene network shared across interneuron subpopulations but not specific to a single one. Furthermore, hierarchical clustering revealed that 218 DKO motoneurons express TARGET 218 genes at levels closer to those of V1, V2a, and V3 interneurons than to those of WT motoneurons (Fig. 3E) . Thus, rather than reinforcing a preexisting low target gene expression in motoneurons, miR-218 establishes the low TARGET 218 expression observed in motoneurons relative to interneurons.
To evaluate miRNA-mediated repression in an unbiased manner, we bioinformatically evaluated the statistical enrichment of binding sites for all miRNAs across the transcriptome of investigated cell types. Using Sylamer (18), we determined the hypergeometric statistical enrichment of 7-bp 3′UTR sequences complementary to known miRNA seed sequences (miRNA seed matches) in transcripts expressed higher or lower in motoneurons versus interneurons (Fig. 4A) . We found that 3′UTR seed matches to miR-218 are significantly enriched in transcripts expressed lower in WT motoneurons versus pooled interneurons (Fig.  4A) , individual spinal interneuron subpopulations, and even distantly located cortical neuron subpopulations (Fig. 4B) (24) . 3′UTR seed matches to miR-218 were not found to be enriched in genes expressed higher or lower in 218 DKO motoneurons (Fig. 4C) . The 3′UTR seed match to miR-124 [a pan-neuronal miRNA abundantly expressed in motoneurons and other CNS neurons (25) ], but not 3′UTR seed matches to miR-218, was overrepresented in transcripts expressed lower in motoneurons versus purified motoneuron progenitors differentiated from embryonic stem cells (Fig. 4, B and C , that is selectively repressed in motoneurons by a single miRNA. When this network is derepressed in 218 DKO mice, motoneurons exhibit severe NMJ defects, hyperexcitability, and cell loss-the pathological hallmarks of motoneuron diseases such as ALS and SMA (1, (26) (27) (28) . The link between miR-218 and motoneuron diseases likely extends beyond phenotypic similarities. Patients suffering from motoneuron diseases carry genetic mutations in ubiquitously expressed RNA processing factors (e.g., TDP-43, FUS, SMN) or expansion repeats in C9ORF72 that sequester RNA binding proteins (1, 2) , but the biological mechanisms that magnify the effects of these changes on motoneurons are unclear. miRNA-dependent regulation-and specifically the repression of miR-218's genetic networkmight be particularly sensitive to defects in these RNA metabolic pathways thought to underlie motoneuron disease. Investigations of the pathways affecting miR-218's biogenesis and the modulation of its genetic network may be critical to understand and tackle these devastating diseases. 
